Eisai’s brain health tool NouKNOW used in Tokyo dementia project Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese Share X Eisai’s brain health tool NouKNOW used in Tokyo dementia project https://pharmaphorum.com/news/eisais-brain-health-tool-nouknow-used-in-tokyo-dementia-project/
Pfizer is first big pharma to tap Truveta’s real-world data platform Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other Share X Pfizer is first big pharma to tap Truveta’s real-world data platform https://pharmaphorum.com/news/pfizer-is-first-big-pharma-to-tap-truvetas-real-world-data-platform/
Single MRI-based brain scan could diagnose Alzheimer’s disease, says study Alzheimer’s disease could be diagnosed from a single MRI brain scan, according to a new study by Imperial Share X Single MRI-based brain scan could diagnose Alzheimer’s disease, says study https://pharmaphorum.com/news/single-mri-based-brain-scan-alzheimers-disease/
Alimetry nabs FDA okay for gastric disorder-diagnosing wearable New Zealand medical tech startup Alimetry has claimed an FDA approval for a wearable device that can be Share X Alimetry nabs FDA okay for gastric disorder-diagnosing wearable https://pharmaphorum.com/news/alimetry-nabs-fda-okay-for-gastric-disorder-diagnosing-wearable/
Canadian comms giant Telus buys digital health player LifeWorks Canadian wireless network carrier Telus has agreed to a C$2.9 billion ($2.2 billion) deal to acquire LifeWorks, a Share X Canadian comms giant Telus buys digital health player LifeWorks https://pharmaphorum.com/news/canadian-comms-giant-telus-buys-digital-health-player-lifeworks/
Lilly partners with Sidekick in digital health alliance A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from Share X Lilly partners with Sidekick in digital health alliance https://pharmaphorum.com/news/lilly-partners-with-sidekick-in-digital-health-alliance/
HiDoc raises $7m and names new CEO as digital tool for IBS launches HiDoc Technologies has secured a cash injection of $7 million to help with the launch of its Cara Share X HiDoc raises $7m and names new CEO as digital tool for IBS launches https://pharmaphorum.com/news/hidoc-raises-7m-and-names-new-ceo-as-digital-tool-for-ibs-launches/
Digital operating room developer Proximie raises $80m Tech startup Proximie has raised $80 million in third-round financing that will be used to further develop its Share X Digital operating room developer Proximie raises $80m https://pharmaphorum.com/news/digital-operating-room-developer-proximie-raises-80m/
Almirall-backed psoriasis support app Claro launches in Europe An alliance between Spanish drugmaker Almirall and digital health company Happify has yielded its first fruit, with the Share X Almirall-backed psoriasis support app Claro launches in Europe https://pharmaphorum.com/news/almirall-backed-psoriasis-support-app-claro-launches-in-europe/
Alliance eyes European ‘single market’ for digital therapeutics There’s a growing body of evidence that digital therapeutics (DTx) can complement other therapies for a wide range Share X Alliance eyes European ‘single market’ for digital therapeutics https://pharmaphorum.com/news/alliance-eyes-european-single-market-for-digital-therapeutics/
Could an eye test spot people at risk of heart attacks? An analysis of images of the retina harvested from the UK Biobank resource suggests that it may be Share X Could an eye test spot people at risk of heart attacks? https://pharmaphorum.com/news/could-an-eye-test-spot-people-at-risk-of-heart-attacks/
AI specialist Charm Therapeutics launches with $50m Series A The UK’s fertile environment for biotechs specialising in artificial intelligence has generated a new player – Charm Therapeutics Share X AI specialist Charm Therapeutics launches with $50m Series A https://pharmaphorum.com/news/ai-specialist-charm-therapeutics-launches-with-50m-series-a/
Sanofi furthers its digital ambitions with Paris accelerator Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up Share X Sanofi furthers its digital ambitions with Paris accelerator https://pharmaphorum.com/news/sanofi-furthers-its-digital-ambitions-with-paris-accelerator/
Owkin bags $180m BMS alliance for cardiovascular clinical trials Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is Share X Owkin bags $180m BMS alliance for cardiovascular clinical trials https://pharmaphorum.com/news/owkin-bags-180m-bms-alliance-for-cardiovascular-clinical-trials/
Abbott makes progress with wearable for diabetic ketoacidosis Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new Share X Abbott makes progress with wearable for diabetic ketoacidosis https://pharmaphorum.com/news/abbott-makes-progress-with-wearable-for-diabetic-ketoacidosis/
Apple adds medication tracking to iPhone and Apple Watch Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will Share X Apple adds medication tracking to iPhone and Apple Watch https://pharmaphorum.com/news/apple-adds-medication-tracking-to-iphone-and-apple-watch/
AI specialist Insilico raises $60m as more projects head to clinic Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more Share X AI specialist Insilico raises $60m as more projects head to clinic https://pharmaphorum.com/news/ai-specialist-insilico-raises-60m-as-more-projects-head-to-clinic/
Eversana aims athletes’ mental coaching at pharma sales reps Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training Share X Eversana aims athletes’ mental coaching at pharma sales reps https://pharmaphorum.com/news/eversana-aims-athletes-mental-coaching-at-pharma-sales-reps/
